Oppenheimer Holdings Inc. reissued their market perform rating on shares of Alcentra Capital Corp. (NASDAQ:ABDC) in a report published on Monday morning.

Other research analysts also recently issued reports about the company. TheStreet upgraded Alcentra Capital Corp. from a hold rating to a buy rating in a research note on Thursday, September 1st. Robert W. Baird downgraded Alcentra Capital Corp. from an outperform rating to a neutral rating and lowered their price objective for the stock from $13.00 to $12.00 in a research note on Monday.

Alcentra Capital Corp. (NASDAQ:ABDC) opened at 12.37 on Monday. The stock has a 50 day moving average price of $12.85 and a 200-day moving average price of $12.37. Alcentra Capital Corp. has a 12 month low of $8.87 and a 12 month high of $13.47.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 5th. Shareholders of record on Saturday, December 31st will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Wednesday, December 28th. This represents a $1.36 dividend on an annualized basis and a yield of 10.99%. Alcentra Capital Corp.’s dividend payout ratio (DPR) is presently 1,046.23%.

In other Alcentra Capital Corp. news, insider David Scopelliti purchased 2,000 shares of Alcentra Capital Corp. stock in a transaction on Thursday, September 8th. The stock was bought at an average price of $12.88 per share, for a total transaction of $25,760.00. Following the transaction, the insider now owns 4,600 shares of the company’s stock, valued at approximately $59,248. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 4.47% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Oppenheimer & Co. Inc. raised its stake in shares of Alcentra Capital Corp. by 2.2% in the third quarter. Oppenheimer & Co. Inc. now owns 12,448 shares of the company’s stock valued at $162,000 after buying an additional 268 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Alcentra Capital Corp. by 107.1% in the third quarter. JPMorgan Chase & Co. now owns 14,273 shares of the company’s stock valued at $185,000 after buying an additional 7,382 shares during the period. Confluence Investment Management LLC raised its stake in shares of Alcentra Capital Corp. by 0.5% in the third quarter. Confluence Investment Management LLC now owns 190,912 shares of the company’s stock valued at $2,480,000 after buying an additional 918 shares during the period. Advisors Asset Management Inc. raised its stake in shares of Alcentra Capital Corp. by 14.0% in the third quarter. Advisors Asset Management Inc. now owns 858,722 shares of the company’s stock valued at $11,155,000 after buying an additional 105,554 shares during the period. Finally, Muzinich & Co. Inc. raised its stake in shares of Alcentra Capital Corp. by 41.3% in the third quarter. Muzinich & Co. Inc. now owns 157,426 shares of the company’s stock valued at $2,045,000 after buying an additional 46,007 shares during the period. Institutional investors and hedge funds own 44.23% of the company’s stock.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

5 Day Chart for NASDAQ:ABDC

Receive News & Stock Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related stocks with our FREE daily email newsletter.